D R Healthcare Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.30 Cr
as on 24-10-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 15.75 Cr
as on 24-10-2024
- Revenue 7491.62%
(FY 2023)
- Profit -500940.60%
(FY 2023)
- Ebitda -359.40%
(FY 2023)
- Net Worth -15.29%
(FY 2023)
- Total Assets 334.55%
(FY 2023)
About D R Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.30 Cr.
The company has closed loans amounting to ₹15.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Minalkunvarba Solanki and Hitesh Sathwara serve as directors at the Company.
- CIN/LLPIN
U85110GJ2006PTC048008
- Company No.
048008
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2006
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at D R Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minalkunvarba Solanki  | Director | 15-Jan-2020 | Current |
| Hitesh Sathwara | Director | 13-Aug-2022 | Current |
Financial Performance of D R Healthcare.
D R Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 7491.62% increase. The company also saw a substantial fall in profitability, with a 500940.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D R Healthcare?
In 2023, D R Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹15.75 Cr
Charges Breakdown by Lending Institutions
- Capital First Limited : 7.02 Cr
- Kotak Mahindra Bank Limited : 4.75 Cr
- State Bank Of India : 3.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2014 | Capital First Limited | ₹7.02 Cr | Satisfied |
| 07 Apr 2012 | Kotak Mahindra Bank Limited | ₹4.75 Cr | Satisfied |
| 03 Sep 2007 | State Bank Of India | ₹3.99 Cr | Satisfied |
How Many Employees Work at D R Healthcare?
Unlock and access historical data on people associated with D R Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D R Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D R Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
